Displaying drugs 12101 - 12125 of 14627 in total
Rosa canina fruit
Experimental
Sepia esculenta bone
Experimental
Pediococcus acidilactici
Experimental
Hepatitis A vaccine (live, attenuated)
Experimental
Aspergillopepsin-2
Experimental
Rabies immune globulin, equine
Experimental
Cardamom
Experimental
Ascophyllum nodosum
Experimental
Frankincense
Experimental
Chinese cinnamon
Experimental
Apple cider vinegar
Experimental
Escherichia coli strain Nissle 1917
Experimental
Vitis vinifera seed
Experimental
Equine collagen
Experimental
Niaouli oil
Experimental
Chamaecyparis obtusa whole
Experimental
Gastrodia elata whole
Experimental
Oxelumab
Oxelumab is under investigation in clinical trial NCT00983658 (A Study of HuMAb OX40L in the Prevention of Allergen-induced Airway Obstruction in Adults With Mild Allergic Asthma).
Investigational
Surzebiclimab
Surzebiclimab is under investigation in clinical trial NCT03744468 (Study of BGB-A425 in Combination With Tislelizumab in Advanced Solid Tumors).
Investigational
Torudokimab
Torudokimab is under investigation in clinical trial NCT03831191 (A Study of LY3375880 in Adults With Moderate-to-severe Atopic Dermatitis).
Investigational
Uliledlimab
Uliledlimab is under investigation in clinical trial NCT04322006 (A Phase I/II Study of TJ004309 for Advanced Solid Tumor).
Investigational
Letaplimab
Letaplimab is under investigation in clinical trial NCT04485052 (Efficacy and Safety Evaluation of IBI188 in Combination With Azacitidine in Treatment of Patients With Acute Myeloid Leukemia).
Investigational
Matched Description: … Letaplimab is under investigation in clinical trial NCT04485052 (Efficacy and Safety Evaluation of IBI188 …
Efmitermant alfa
Efmitermant alfa, a locally-acting GDF/activin ligand trap, is under investigation in clinical trial NCT03124459 (Study of ACE-083 in Patients With Charcot-marie-tooth Disease).
Investigational
Axalimogene filolisbac
Axalimogene filolisbac is under investigation in clinical trial NCT02853604 (Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer).
Investigational
Glutazumab
Glutazumab is a novel long-lasting GLP-1/anti-GLP-1R antibody fusion protein exerting anti-diabetic effects.
Investigational
Displaying drugs 12101 - 12125 of 14627 in total